AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
Allergy Therapeutics Delivers Higher-Than-Expected EPS for Full Year 2024
November 28, 2024 07:59 PM AEDT| By Team Kalkine MediaHighlights:,Allergy Therapeutics reports a 7.4% decrease in revenue for the full year 2024.,Net loss narrows by 6.6%, with an improved loss per share compared to FY 2023.,The company’s revenue is forecast to grow 19% annually over the next two years,...
Spire Healthcare Increases Shareholder Value with Share Repurchase
November 28, 2024 07:16 PM AEDT| By Team Kalkine MediaHighlights:,Spire Healthcare has completed the purchase of 44,939 shares under its ongoing share buyback program.,The share buyback is part of Spire Healthcare’s strategy to enhance shareholder value and optimize capital structure.,Following the repu...
Oxford Nanopore Technologies Partners with UK Biobank for Groundbreaking Epigenetics Study
November 28, 2024 02:34 AM AEDT| By Team Kalkine MediaHighlights,Innovative Research:,Oxford Nanopore will analyze 50,000 UK Biobank samples to investigate disease mechanisms through epigenetic sequencing.,Cutting-Edge Technology:,Comprehensive methylation marker insights provided without complex chemic...
Oxford Nanopore and UK Biobank Work Together on Epigenetic Innovation
November 27, 2024 07:39 PM AEDT| By Team Kalkine MediaHighlights:,Oxford Nanopore Technologies collaborates with UK Biobank to develop the world’s largest epigenetic dataset.,The initiative will involve 50,000 participant samples aimed at advancing research in disease mechanisms, especially cancer and d...
GSK’s Liquid Meningitis Vaccine Cleared by EU Authorities
November 27, 2024 07:34 PM AEDT| By Team Kalkine MediaHighlights:,GSK’s liquid meningitis vaccine, Menveo, has received approval from the European Commission for use in children, adolescents, and adults.,The liquid formulation eliminates the need for reconstitution, simplifying the vaccination process.,...
AstraZeneca PLC (AZN) attracts hedge fund attention for its cancer treatment potential
November 25, 2024 09:36 PM AEDT| By Team Kalkine MediaHighlights:,Cancer remains one of the leading global health challenges, with millions of new cases and deaths reported annually.,Pharmaceutical and biotech companies are advancing cancer therapies, including innovations in radiopharmaceuticals and mR...
Renalytix plc Financial Performance for First Quarter of Fiscal Year 2025 Released
November 21, 2024 12:56 AM AEDT| By Team Kalkine MediaHighlights:,Continued test ordering growth at a prominent New York-based physician group practice.,Cash burn reduced to an approximate monthly rate by the end of fiscal year 2025.,Financing commitments completed, providing a strengthened cash positio...
SkinBioTherapeutics and Croda Finalize Partnership for SkinBiotix Commercial Launch
November 19, 2024 11:48 PM AEDT| By Team Kalkine MediaHighlights:,Commercial Partnership Secured:,SkinBioTherapeutics to receive royalties on global sales of Croda’s products utilizing SkinBiotix technology.,Innovative Cosmetics Platform:,Extensive testing reveals enhanced benefits of SkinBiotix, elevat...
GSK’s linerixibat successfully meets primary study endpoint
November 19, 2024 11:34 PM AEDT| By Team Kalkine MediaHighlights:,GSK's linerixibat candidate shows positive results in Phase III trial for cholestatic pruritus in primary biliary cholangitis (PBC).,The trial met its primary endpoint with a statistically significant improvement in itch relief over 24 we...
LungLife AI Advances Commercialisation of Lung Cancer Diagnostic Test
November 19, 2024 11:04 PM AEDT| By Team Kalkine MediaHighlights:,Positive Reception for LungLB:,Doctors in the Early Access Program report encouraging feedback, with orders placed and integration evaluations underway.,Medicare Coverage Application Pending:,LungLife AI aims to submit its MolDx program a...
Revolutionizing Medicine: The Expanding Frontier of mRNA Technology
November 19, 2024 09:51 PM AEDT| By Team Kalkine MediaHighlights:,mRNA’s Broad Potential:,Beyond COVID-19 vaccines, mRNA technology is revolutionizing treatments for cancer and infectious diseases.,BioNTech and Moderna Lead the Way:,Both companies showcase unique strengths, from BioNTech's oncology focu...
SkinBioTherapeutics plc (SBTX:AIM) Finalizes Commercial Agreement with Croda Beauty Care for SkinBiotix™ Technology
November 19, 2024 06:42 PM AEDT| By Team Kalkine MediaHighlights:,Commercial terms finalized with Croda, based on successful results from additional clinical studies.,SkinBioTherapeutics expects to be cash flow positive from FY2025, with no further capital raises required.,CEO Stuart Ashman to discuss t...
Spire Healthcare Completes Execution of Share Buyback Program
November 18, 2024 08:56 PM AEDT| By Team Kalkine MediaHighlights:,Spire Healthcare Group PLC has initiated a share buyback program, repurchasing 50,000 shares.,The share buyback reduces the total number of shares in circulation to 403,594,688.,Spire Healthcare remains a significant entity in the UK heal...
Halma plc (HLMA: LSE) Expands Healthcare Sector with Acquisition of Lamidey Noury Medical
November 18, 2024 06:25 PM AEDT| By Team Kalkine MediaHighlights:,Halma acquires Lamidey Noury Medical for €50m (£42m) to enhance its portfolio of advanced medical technologies.,Lamidey Noury, based in France, manufactures electrosurgical devices for minimally invasive surgery, with products sold in ove...
Pharma Stocks Sink After Trump's Controversial Health Secretary Appointment
November 16, 2024 02:35 AM AEDT| By Team Kalkine MediaHighlights:,Pharma Market Shock:,Appointment of vaccine critic Robert F Kennedy Jr as US health secretary spooked global pharmaceutical and biotech stocks, triggering a sharp sell-off.,Vaccine Makers Hit Hard:,Shares in Moderna, BioNTech, Pfizer, and...
ANGLE PLC’s Liquid Biopsy Technology Paves the Way for Breakthroughs in Cancer Diagnostics
November 15, 2024 08:35 PM AEDT| By Team Kalkine MediaHighlights:,Innovative Liquid Biopsy Advances:,ANGLE PLC presented new data on Parsortix-based assays for lung and breast cancer diagnostics, highlighting its potential to revolutionise personalised treatment.,Improved Detection of PD-L1 and HER2 Mar...
Pharma Stocks Sink as Trump's Health Secretary Appointment Sparks Market Fears
November 15, 2024 07:30 PM AEDT| By Team Kalkine MediaHighlights:,Market Reaction,:,GSK and AstraZeneca lost,nearly £7 billion,in combined market value following the appointment of Robert F Kennedy Jr., a known vaccine skeptic, as the new US Health Secretary.,Sector Uncertainty,:,The pharmaceutical indu...
PDS Biotech Streamlines Clinical Trials Amid Positive Pipeline Developments
November 14, 2024 07:36 PM AEDT| By Team Kalkine MediaHighlights:,Optimized Phase 3 Trial Design,: PDS Biotech revises VERSATILE-003 trial for cost and timeline efficiency, seeking FDA clearance.,Promising Clinical Data,: Versamune® HPV shows strong safety and efficacy in ongoing studies, including cerv...
AstraZeneca Raises Full-Year Forecast as Oncology Portfolio Drives Strong Growth
November 13, 2024 11:00 AM AEDT| By Team Kalkine MediaHighlights:,Upgraded Sales and Earnings Forecast:,AstraZeneca raised its 2024 guidance for both sales and earnings for the second time in four months, now expecting high-teens growth in revenue and earnings per share.,Robust Oncology Performance:,The...
AstraZeneca Faces Uncertainty Amid Chinese Criminal Probe as Business Grows
November 13, 2024 11:00 AM AEDT| By Team Kalkine MediaHighlights:,AstraZeneca under Investigation:,Chinese authorities have detained AstraZeneca's top executives, including its China president, over allegations of illegal importation of oncology medicines.,CEO’s Commitment to Cooperation:,Pascal Soriot...
AI on the Rise: A Look at Top AI Companies and Their Stocks